Advertisement
U.S. markets close in 4 hours 22 minutes

ArriVent BioPharma, Inc. (AVBP)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Visitors trend2W10W9M
27.37-0.08 (-0.29%)
As of 11:35AM EST. Market open.
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
Total Revenue
0
0
0
Operating Expense
93,721
74,590
36,906
Operating Income
-93,721
-74,590
-36,906
Net Non Operating Interest Income Expense
12,673
5,257
0
Pretax Income
-81,048
-69,333
-36,906
Net Income Common Stockholders
-81,048
-69,333
-36,906
Diluted NI Available to Com Stockholders
-81,048
-69,333
-36,906
Basic EPS
-1.83
-2.17
-1.15
Diluted EPS
-1.83
-2.17
-1.15
Basic Average Shares
31,957
31,957
31,957
Diluted Average Shares
31,957
31,957
31,957
Total Operating Income as Reported
-93,721
-74,590
-36,906
Total Expenses
93,721
74,590
36,906
Net Income from Continuing & Discontinued Operation
-81,048
-69,333
-36,906
Normalized Income
-81,048
-69,333
-36,906
Interest Income
12,673
5,257
0
Net Interest Income
12,673
5,257
0
EBIT
-93,721
-74,590
-36,906
EBITDA
-93,721
-74,590
-36,906
Net Income from Continuing Operation Net Minority Interest
-81,048
-69,333
-36,906
Normalized EBITDA
-93,721
-74,590
-36,906
Tax Rate for Calcs
0
0
0
Tax Effect of Unusual Items
0
0
0